top of page
About Us
Meaning of "Heka"
Egyptian god of
Magic and Medicine
HekaBio is an asset-light emerging commercial-stage biopharma and MedTech operating company that in-licenses early, de-risked assets to commercialize in Japan and the APAC region.
We conduct clinical trials, secure regulatory and pricing approvals and optimize commercial opportunities within two to four years through our strong network of partners in pharma,
MedTech, and hospitals.
Our multicultural team has 50+ approvals in Japan and a stellar
in-licensed portfolio at an inflection point for commercial sales beginning in H1 2026.
Our Mission
Accelerating patient access to world-leading healthcare solutions throughout the APAC region, starting with Japan
Our Core Values
bottom of page